2026 Calls for a Global Health System Connectivity Compact: EHR/EMR, Interoperability, and Cybersecurity Vendors Urged to Protect Continuity of Care During Conflict and Recovery
Through High-Profile Ambassadors and Major Partnerships, ZetrOZ Systems Expanded Reach of sam Device in 2025
Scott Leune Names 2026 Sponsors Selected to Support Dental Practice Growth and Operations
Healthcare Cloud Computing Market to Reach $54.72 B by 2033 | CAGR 13% | According to DataM Intelligence Report
New Horizon Medical Solutions Announces the Acquisition of the Applied Tissue Technologies Business Assets
LITTLETON, Colo., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a craft brewery owned by Tilray Brands, Inc. company (NASDAQ:...
WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory...
Veteran life sciences industry financing leader appointed as new Board memberHOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience,...
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Leaders in the fields of ubiquitin biology and targeted protein degradation (TPD)...
Dermatology2Go focuses on online skin care, without waiting times and with reliable information Bert van Gerwen, Founder/CEO Bert van Gerwen,...
WATFORD, United Kingdom and BERWYN, Pa., Sept. 09, 2025 (GLOBE NEWSWIRE) -- CHAPPER healthcare, AscellaHealth’s global pharmaceutical wholesaler, distributor and...
Persephone Persephone - A First-Of-Its-Kind Synbiotic Newly released data shows that nine in ten babies lack critical gut microbes needed...
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small...
NEW YORK and PARIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rarecells, a pioneer in liquid biopsy technologies, today presented new...
De nouvelles données démontrent que l’association avec l’amivantamab réduit significativement les mutations courantes de résistance à l’EGFR et au MET...
Scenic Biotech taps Dr. Bürli as Chief Scientific Officer to lead development of innovative drug candidate pipeline fueled by the...
– Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4...
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular...
THOUSAND OAKS, Calif. and TOKYO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (TSE:4151) today...
Calgary, Alberta--(Newsfile Corp. - September 9, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
Avidion brings clarity to immune drug-tumor interactions, helping scientists identify better cell therapy candidates, understand mechanisms, and advance with confidence....
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Haven House Sober Living has been nominated for Best...
Enabling clinicians to stay in flow-anytime, anywhere-with an intelligent, cloud-powered Enterprise Imaging Platform that is streaming-enabled, deeply integrated, and tailored...
Funding will drive development across Labs' 7 core Labs and support the fall launch of Yuhmmy App 2.0, the Social-Taste...
Data strongly supports the technology for effective, efficient and safe probe placement versus blind intubation MINNEAPOLIS, Sept. 8, 2025 /PRNewswire/ --...
